Health in Brainport.
A snapshot of the Eindhoven health ecosystem: startups & scaleups founded from 2010 onward, still operational, with funding raised. Share relative to the full Brainport ecosystem (139 funded companies).
Proven traction, clinical impact in sight.
ONWARD Medical
Spinal cord stimulation for spinal cord injury. ARC-EX received FDA De Novo clearance in Dec 2024 — the first non-invasive SCS worldwide. Pivotal trial: 90% of participants improved arm/hand function.
Salvia BioElectronics
Ultra-thin implant for chronic migraine. First Dutch patient implanted at Erasmus MC. RECLAIM pivotal study running internationally.
Ambagon Therapeutics
Molecular glue stabilizers on 14-3-3 interactions. A new route to previously undruggable oncology targets.
MicroSure
MUSA-3 microsurgical robot. Lymphatic surgery, reconstruction, urology. Anastomoses of vessels <0.3 mm become surgically feasible.
Onera Health
Patch-based home polysomnography. Multicenter validation 2025: comparable to in-lab PSG. Relieves sleep labs of waiting lists.
Sirius Medical
Pintuition: magnetic seed for localising non-palpable breast tumours. Validated in NL (ETZ Tilburg) and the UK NHS.
Diagnostics, pathology, wound care and monitoring.
ShanX Medtech
FLORA platform: ultra-fast Antimicrobial Susceptibility Testing. Cuts 2-day turnaround to hours — directly relevant to antibiotic stewardship.
Xyall
Tissector: automated tissue microdissection for molecular pathology. Removes the subjective manual step before NGS/PCR.
PlasmaCure
PLASOMA: cold-plasma pad for chronic wounds. CE-marked, reimbursed in NL. Faster healing for diabetic foot and venous leg ulcers.
SmartQare
viQtor wearable for continuous vital-signs monitoring on hospital wards. Replaces periodic spot checks, flags deterioration earlier.
Ambyon — the robot that gives time back.
Care professionals spend up to 2 hours a day on logistics: fetching medication, delivering lab samples, moving supplies. Time that doesn't go to the patient, in a sector with chronic staff shortages.
Ambyon One: an autonomous logistics robot that learns to navigate the chaos of a hospital. Anticipates doors, bed traffic and people. Moves medication, samples and supplies.
Not a care robot, not a replacement. A supporting colleague that takes away the side tasks, so care can be about care again.
"If we do nothing now, we won't be able to count on the care we need in the years ahead."— Willem-Jan Lamers, CEO Ambyon · source: IO+ (Apr 2026)
Founded ≥2022, first funding secured.
VivArt-X
Personalised regenerative solution for breast reconstruction after breast cancer.
AIKON Health
Wearable for cardiologists and heart failure nurses. Better at-home monitoring for 15M+ EU heart failure patients.
ARTIC Technologies
Magnetic Artificial Cilia: a nature-inspired micropump. First application: dynamic 3D cell-culture platforms.
Since 2022, seven new health companies in Brainport have raised capital. Alongside the three shown here, more sit in pre-seed / seed.